← FDA DRUG APPROVALS

FDA ANDA · ANDA213576

ELUXADOLINE

Sponsor: MSN PHARMACEUTICALS INC

APPLICATION
ANDA213576
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)

Products

ELUXADOLINENone (Tentative Approval)
ELUXADOLINE 100MG · TABLET · ORAL
ELUXADOLINENone (Tentative Approval)
ELUXADOLINE 75MG · TABLET · ORAL

Approval history

2021-09-23UNKNOWN · Original · standard — Letter ↗TA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →